Gums and mucilage are mainly explored for its various applications in dosage form development. Salvia hispanica (Lamiaceae) i.e. Chia seed mucilage mainly composed of xylose, glucose and methyl glucuronic acid that forms a branched polysaccharide of high molecular weight. The present study strives to investigate the disintegration ability of Salvia hispanica mucilage in the formulation of fast dissolving tablets of selected model drug indomethacin. Indomethacin belonging to the category of NSAIDs and is used as a therapeutic agent for relieving pain, inflammation and joint stiffness. Salvia hispanica mucilage was isolated and characterized by physicochemical parameters. Indomethacin tablets (F1-F5) were formulated by direct compression method using S. hispanica mucilage powder in varying concentration range of 2%, 4%, 6%, 8% and 10% respectively. Crospovidone (6%) was used as synthetic disintegrating agent for comparison. Micro crystalline cellulose was used as tablet diluent, mannitol, talc and magnesium stearate were used to enhance mouth feel and as lubricants respectively. All the formulations were evaluated for their pre and post compression parameters like tablet hardness, thickness, % friability, wetting time, drug content, disintegration time which was found to be in permissible limits. Drug excipient compatibility study was carried out using FTIR technique. The formulation F3 containing 6% of Salvia hispanica mucilage exhibit maximum drug release of 98.5% in 30 minutes, F4 and F5 formulations containing 8% and 10% of Salvia hispanica mucilage showed 82.4% and 80.5% drug release in 30 minutes. Results of in vitro drug released kinetic study indicated that the optimized formulation F3 followed Korsmeyer Peppas model with R 2 value of 0.9793. Stability studies performed on F3 formulation indicated that the prepared tablets remain stable for the period of 90 days and showed no change in in vitro drug release pattern. Various investigations have demonstrated that the S. hispanica seed mucilage can be successfully used as a natural superdisintegrant which is comparable to various synthetic disintegrants used in the formulation of fast dissolving drug delivery systems.
INTRODUCTION
Oral administration is the most familiar and preferential route for the delivery of therapeutic agents to the patients. 1 Mainly, tablets are medications of choice for patients because of dose precision, self-medication, avoidance of fear of needles, economical therapy, compactness, easy administration and patient compliance. No requirement for the maintenance of sterile conditions is there, therefore manufacturing cost is low. 2 Tablet formulations include the therapeutic active component i.e., active pharmaceutical ingredient (API) and the excipients which are the pharmaceutically inactive components. Regardless of their inactivity, excipients possess specific functionalities affecting the biopharmaceutical action of the formulation. The excipients incorporated into the tablet formulations are binders, diluents, disintegrants, lubricants, preservatives, colorants and flavoring agents. 3 Disintegration of the tablet is the important step involved in the release of the drug, therefore, the most essential excipient amidst all is the disintegrant which is responsible for the breaking up of the dosage form into smaller particles after it has been ingested and further allowing the dissolution and ultimately the absorption of the drug. 4 The disintegrant property can be modified for the development of fast dissolving/disintegrating tablets (FDT) which are beneficial for paediatric, geriatric, dysphagic, bedridden and uncooperative patients as conventional tablets might pose a difficulty in swallowing because of coughing, motion sickness, abrupt episodes of allergic attack or in case of unavailability of water. FDTs are novel dosage form which utilizes superdisintegrants for immediate and complete disintegration of the tablet, generally within the range of a few seconds to less than a minute, when placed on the tongue, thereby leading to drug release in the saliva. They are also known as 'quick-dissolving', 'orodispersible', 'melt-in-mouth' or 'mouth-dissolving tablets'. 5 Diverse factors influencing the disintegration process of the tablet include the particle size, moisture content, compression force, type and properties of the disintegrant, tablet hardness, nature of the drug, compatibility with other ingredients and the process of addition as well as mixing. 6, 7 The crucial mechanisms involved in the tablet disintegration process include swelling, deformation, wicking, enzymatic reactions and repulsions between the particles. 8 Different categories of superdisintegrants include natural (like Gums and mucilage) and synthetic superdisintegrants (croscarmellose sodium, crospovidone, carmellose, sodium starch glycollate etc.). Various Gums and mucilage such as Mangifera indica gum, Locust Bean gum, Fenugreek seed mucilage, Ficus indica fruit mucilage, Lepidium sativum mucilage, etc. have been utilized as superdisintegrant in the formulation of FDT. Additional advantages of natural polymers include easy accessibility, biocompatibility and lower cost as compared to synthetic ones. 9 Chia seeds are obtained from Salvia hispanica, a herbaceous plant belonging to the family Lamiaceae. It is a consumable seed having remarkable therapeutic effects as well as nutritional value due to the presence of high quality carbohydrate (41%), fat (30-33%), protein (15-25%) and dietary fibre (18-30%) and mucilage. It is an excellent source of omega-3 fatty acid, antioxidants as well as various polyphenolic compounds such as caffeic acid, quercetin, chlorogenic acid, kaempferol and myricetin. 10 The polysaccharides that make up the mucilage network of chia seeds are located in the outer seed coat layers and are composed of β-D-xylopyranosyl, α-D-glucopyranosyl and 4-O-methyl-α-D-glucopyranosyluronic acid. Upon addition of water the polysaccharides exudate, absorb water and unravel to full extension. Chia seeds i.e. Salvia hispanica mucilage gels can be used as pharmaceutical excipients in drug delivery. 11 The present study strives to investigate the disintegration ability of Salvia hispanica mucilage in the formulation of FDT of the selected model drug Indomethacin. Indomethacin belongs to NSAID and is used as a therapeutic agent for relieving pain, inflammation and joint stiffness. The drug is included in BCS class II drug (poorly aqueous soluble and highly permeable), so it is worth to develop FDT of Indomethacin to enhance its solubility and bioavailability.
METHODOLOGY

Materials
Salvia hispanica seeds were procured from the local market of Patiala and authentication of the sample was confirmed from Department of Pharmacognosy, Chitkara University Punjab. Indomethacin was obtained as gift sample from Triko Pharmaceutical Rohtak. Crospovidone, Microcrystalline cellulose, Mannitol, magnesium stearate was purchased from Loba Chemie Ltd. Mumbai, India.
Isolation of mucilage
The seeds of Salvia hispanica were soaked in water for overnight (seed-solvent ratio was 1:20), boiled for half an hour and mixed on magnetic stirrer for 1 hour so that the mucilage releases completely into water. The resulting mixture was centrifuged at 5000rpm for 50 min, after which three different layers were formed. 11 Only the gel layer was collected and dried in a hot air oven at 50°C. The product was grounded, passed through the sieve no. 80 and then stored at room temperature in desiccators for further use.
Physicochemical evaluation of mucilage
Isolated mucilage was evaluated for various physicochemical properties. 12
Drug excipient compatibility studies
Drug excipient compatibility studies were performed with the help of Fourier transforms infrared (FTIR) spectroscopy. FTIR spectra (range of 3500-500 cm -1 ) of the Indomethacin, Salvia hispanica mucilage and combined mixture of both (1:1) were taken (Bruker Alpha T).
Standard calibration curve of Indomethacin
For preparing the standard calibration curve of Indomethacin, 100 mg drug was weighed and transferred to 100 ml of volumetric flask. The drug was dissolved in 100 ml of phosphate buffer pH 6.8 (stock I). 10 ml solution was withdrawn from stock I and diluted upto 100 ml with phosphate buffer pH 6.8(stock II). Different dilutions were prepared by pipetting out 0.2, 0.4, 0.6, 0.8, 1 and 2 ml from stock solution II and then finally adjusting the volume upto 10 ml. The absorbance of all the resulting solutions was measured at 325 nm with the help of UV-VS spectrophotometer (Systronics). 13
Formulation of Fast Dissolving Tablets of Indomethacin using Salvia hispanica mucilage
Fast dissolving tablets of Indomethacin (F1-F6) were prepared by direct compression method. The mucilage of Salvia hispanica was used in varying concentrations such as 2%, 4%, 6%, 8% and 10% as superdisintegrant. Microcrystalline cellulose was used as diluent, mannitol as filler, talc as glidant and magnesium stearate as lubricant. All the constituents were weighed according to the composition given in Table 1 , sifted through mesh # 60 and mixed thoroughly in ascending order. The formulated blend was then examined for its pre-compression parameters. These formulations were compared with the standard formulation F6 containing crospovidone as superdisintegrant. 
Pre compression parameters
The different powder blends were evaluated for pre compression parameters by finding the bulk density, tapped density, Carr's index, Angle of repose and Hausner ratio according to methods specified in pharmacopoeia. 14
Evaluation of tablets
The prepared tablets were characterized for different post compression parameters such as weight variation, hardness, % friability, thickness, wetting time, drug content and disintegration time. The hardness of the tablets was assessed with the help of Monsanto hardness tester. It was done by taking the average value of any three tablets from every batch. Friability was tested by taking 20 tablets and placing the weighed tablets in the friability chamber (Roche friability tester) for 4 min at 25±1 rpm, and then percentage of the weight loss was determined. Disintegration test was performed in phosphate buffer of pH 6.8 at 37 ± 1 °C. 15 Thickness of tablets was determined using vernier caliper (Mitutoyo Dial Thickness Gauge, Mitutoyo, Japan). Wetting time was recorded by taking 10 ml of phosphate buffer pH 6.8 in petridish, over this fourfold tissue paper was placed and a tablet was carefully placed over this. Time required for a tablet to wet was recorded as wetting time. For determination of drug content ten tablets from each formulation batch was taken randomly and triturated to fine powder. Weight of powder equivalent to 150mg was taken in phosphate buffer pH 6.8 and assayed for drug content uniformity using double beam UV -visible spectrophotometer at λ max 325 nm.
In vitro drug dissolution study
In vitro release of the drug was evaluated by Lab India Dissolution Apparatus (LABINDIA DS 80 00, India), using phosphate buffer of pH 6.8 as the dissolution media (900 ml) which was maintained at a temperature of 37±1°C for half an hour, at 75 rpm. After specified time interval, 5ml of sample was withdrawn and concurrently replaced with the same volume of dissolution media. Spectrophotometrical analysis of the samples were measured at a wavelength of 250 nm, and % cumulative drug release was calculated. 16
Drug release kinetics
Mechanism of drug release and kinetic followed was studied by fitting the data of drug release in different kinetic models i.e. zero order, first order, Higuchi, Hixson-Crowell and Korsmeyer-Peppas model. 17, 18 Zero order equation:
Q t = K 0 t Q t = percentage of drug release in time t K 0 = release rate constant.
First order equation:
In (100-Q t ) = In100-K 1 t 
Stability studies
Stability testing of F3 formulation selected on the basis of release studies was carried out as per the ICH stability testing guidelines at 40ºC with 75% relative humidity, tablet samples were loaded in stability test chamber (Remi Instruments, India) and samples were withdrawn at different time points 15, 30, 45, 60 and 90 days. 19 Samples were evaluated for disintegration time, in vitro drug release and uniformity in content.
RESULTS AND DISCUSSION
Physicochemical evaluation of mucilage
Mucilage from the seeds of Salvia hispanica was isolated with the help of standard procedure. The total yield of mucilage obtained was 12 %. The isolated mucilage was greyish white in colour and mucilaginous in taste. The physicochemical properties of isolated mucilage were analyzed and the results are listed in Table 2 . 
12.
Test for glycosides +ve
13.
Test for mucilage (Ruthenium red test) +ve
14.
Test for reducing sugar (Fehling's test) +ve
15.
Mounting with Iodine Solution +ve
16.
Test for uronic acid +ve *Results are expressed as mean (n=3), +ve=Positive, -ve = Negative 
Standard calibration curve of Indomethacin
Drug-excipients compatibility study
FTIR spectra of indomethacin, Salvia hispanica mucilage and mixture of drug and mucilage are given in Figure 2 . Spectral analysis indicated all the important peaks of drug in the FTIR of drug and mucilage mixture which indicates that indomethacin is functionally compatible with the mucilage. 
Pre-compression parameter
Six formulation batches of indomethacin tablets (F1-F6) were formulated, each having different concentration of mucilage. The flow properties of different powder blends were analyzed by angle of repose, Carr's index and hausner ratio. The angle of repose values lie within the range 28.65 -21.6, which indicates excellent flow ability. Carr's index between 19 -11% and hausner ratio values ranging between 1.29-1.21 shows good flow characteristics. Table 3 depicts the outcome of pre compression parameters of formulation blends (F1-F6). 
Post compression parameter
The hardness value of all the tablets was in the range of 1.5-2.5 kg/cm 2 . The friability test was done to examine the durability and depict how much mechanical stress the tablets can withstand during their manufacturing, distribution and handling by the customer. According to IP, the percent friability value should not exceed above 1%. All the prepared tablet formulations show values between 0.3-0.75percent, which means the friability test, was passed by all of them as per the standard value. The disintegration time has a range of 19-72 sec and it decreased with an increase in concentration of mucilage. Table 4 depicts the results for all the evaluation parameters. 
Drug release
In vitro drug release study is shown in Figure 3 . The formulation F3 containing 6% of Salvia hispanica mucilage exhibit maximum drug release of 98.5% in 30 minutes, F4 and F5 formulations containing 8% and 10% of Salvia hispanica mucilage showed 82.4% and 80.5% drug release in 30 minutes, which indicated that the amount of drug released from the tablets decreased as the concentration of mucilage increased. This can be due to the fact that as the concentration of mucilage increases, it causes an increase in the apparent viscosity. Further, the intermolecular motion of the particles gets restricted and leads to the formation of an interfacial film which slows down the drug release. 20 Figure 3 . In Vitro drug release plot of F1-F6 formulations.
Release kinetic study
Results of in vitro drug released kinetic study as shown in Table 5 indicated that the optimized formulation F3 followed Korsmeyer Peppas model with R 2 value of 0.9793. 
Stability studies
As per the ICH guidelines, stability studies were performed on the promising formulation F3 under the condition of 40±2°C/75±5% RH for 90 days which disclosed that no remarkable variation in the colour, hardness, disintegration time, drug content and in vitro drug release were encountered. This shows the stability of the prepared optimized formulation. Table 6 depicts the corresponding outcomes of the tests performed. Salvia hispanica mucilage has a potential to be used as superdisintegrants in place of currently marketed synthetic superdisintegrating agent.
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